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Perspective
Mathematical Models for a New Era of 
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T
he renewed focus on malaria 
control and eradication in 
recent years has shifted the 
design of malaria control programs 
away from short-term, local solutions 
towards more wide-ranging and 
long-term strategies. This new era of 
malaria control will require sustained 
commitment and funding, with 
proposed control programs being 
evaluated in terms of geographic 
scope and long-term feasibility [1]. 
Because this type of evaluation 
cannot be done experimentally, 
mathematical modeling has emerged 
as a popular tool for comparing the 
possible strategies for the control and 
elimination of malaria.
Historically, the mathematical 
models of Ross, Macdonald, and 
Dietz gave us insights into the power 
of certain malaria control strategies, 
such as targeting female anopheline 
mosquitoes and using integrated 
approaches for malaria control [2]. 
These and other early modeling 
efforts [3–5] contributed to policy and 
provoked widespread discussion and 
new theoretical and experimental work. 
Early models usually had simple designs 
aimed at understanding the basic 
principles of the parasites’ population 
biology and evolution. These models 
gave us a threshold principle in 
mosquito control, which states that 
mosquito numbers need only to be 
reduced below a certain threshold in 
order to set the parasites on a path 
to extinction, as well as combination 
therapies as a means of delaying 
resistance evolution. With increasing 
computing power over the past 
decades, mathematical models have 
become more detailed and complex. 
Recently, the largest malaria modeling 
project known to date was funded by 
the Bill & Melinda Gates Foundation 
and uses a network of volunteer 
computers to run many variations of 
a highly complex malaria model [6]. 
While these complex models can make 
specific, quantitative predictions about 
strategies for control, simple models 
are often more appropriate for deriving 
general principles about malaria 
epidemiology. Both approaches will be 
important for developing coordinated 
malaria control policies. 
Effects of Antimalarials on 
Transmission and Incidence 
In this issue of PLoS Medicine, Lucy 
Okell and colleagues present a 
mathematical model exploring how 
a switch in antimalarial drug use 
to artemisinin-based combination 
therapies (ACT) will affect malaria 
prevalence and incidence in endemic 
regions [7]. ACTs, increasingly 
used as a first-line treatment for 
uncomplicated malaria, work rapidly 
and act on the transmission stages of 
the parasite. Their role in reducing 
transmission makes them a potentially 
important component of future 
malaria elimination and eradication 
efforts. Theoretical studies of the kind 
presented by Okell and colleagues 
provide valuable insights into how best 
to use ACTs in different regions. 
Using data from a large cross-
sectional survey of individuals from 
six different transmission settings in 
Tanzania to estimate the parameter 
inputs of the model, Okell and 
colleagues compare the effects of ACT 
introduction in areas of high and low 
malaria transmission. The model is 
somewhat complex (as indeed are 
malaria infections), but this complexity 
is necessary to include some important 
details about disease progression and 
superinfection. The model is simple 
enough, however, that a careful reading 
of the supplementary materials suffices 
for the interested reader to understand 
its core components and mechanisms. 
It is also simple enough that it can be 
run repeatedly on a personal computer 
to assess how changes in the model 
assumptions would affect the results.
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Linked Research Article
This Perspective discusses the 
following new study published in PLoS 
Medicine:
Okell LC, Drakeley CJ, Bousema T, 
Whitty CJM, Ghani AC (2008) Modelling 
the impact of artemisinin combination 
therapy and long-acting treatments 
on malaria transmission intensity. PLoS 
Med 5(11): e226. doi:10.1371/journal.
pmed.0050226
Lucy Okell and colleagues predict the 
impact on transmission outcomes of ACT 
as first-line treatment for uncomplicated 
malaria in six areas of varying 
transmission intensity in Tanzania.PLoS Medicine  |  www.plosmedicine.org 1543 November 2008  |  Volume 5  |  Issue 11  |  e231
One general prediction of the model 
with potentially important policy 
implications is that gametocytocidal 
drugs, such as artemisinins and 
8-aminoquinolines, may reduce malaria 
transmission more effectively in low-
transmission settings, while drugs with 
longer prophylactic effects might have 
a bigger impact in high-transmission 
settings where biting is much more 
frequent. This result can be tested 
in more detail via independently 
built models working under different 
assumptions and using data coming 
in from the field. If true, the result 
would provide guidance for drug 
choice in local malaria control. The 
implications are that control programs 
in high-transmission areas should 
use slowly eliminated antimalarials 
and other control measures to lower 
transmission, and then introduce 
specific gametocytocidal drugs as these 
measures take effect and transmission 
intensity falls. This result does not take 
into account the potential for drug-
resistance evolution.
An important quantitative prediction 
of the model is that prevalence 
reductions in the Tanzania study can 
only be as high as 50%, even with 100% 
ACT coverage. Another prediction 
is that this maximum prevalence 
reduction would be lower in high-
transmission areas where most parasites 
live in asymptomatic individuals. 
Asymptomatic carriage, transmission 
before treatment, and dormancy 
(hypnozoites) in P. vivax and P. ovale 
are the principal reasons why improving 
access to drug treatments alone may not 
eliminate malaria (although improving 
ACT coverage alone has had some 
notable and well documented successes 
[8]). Fortunately, we will not be relying 
on drugs alone in our control efforts; 
increased drug availability will be 
combined with distribution of free 
long-lasting insecticide-treated bednets 
and, where appropriate, indoor residual 
spraying and other methods of vector 
control (and even, perhaps, a vaccine). 
Mathematical modeling will continue 
to provide insights into the best ways to 
combine these different approaches to 
malaria control. 
Role of Mathematical Models in 
Containing Drug Resistance 
We predict an increase in malaria 
mathematical modeling and a danger 
of increased confusion among policy 
makers as each investigation strives 
for a novel result of “interest.” Malaria 
models predictably generate heat, but 
less often light. The keys to a sound and 
understandable modeling conclusion 
are appropriate design, working within 
the model’s assumptions, a careful 
analysis of the model’s sensitivity 
to these assumptions, and a clear 
statement of the model’s limitations. 
Following these basic precepts will make 
modeling accessible to the medical and 
public health communities, who need 
to trust and understand the modelers’ 
recommendations. In predicting 
the effects of antimalarial drugs on 
malaria incidence and prevalence, 
we have to be clear that our estimates 
of transmission dynamics, and in 
particular the effects of antimalarial 
drugs on malaria transmission and their 
interaction with host immunity, are 
poor. Research on this critical area has 
not kept up with developments in other 
areas of malaria research. 
With the caveats above in mind, Okell 
and colleagues provide us with a useful 
predictive model, which gives a picture 
of short-term results in Tanzania under 
the ideal condition of 100% ACT 
coverage. Realistically, though, ACT 
coverage following introduction in 
endemic regions might be 30%–60%, 
especially in the short term [9]. Any 
long-term policy with a high coverage 
goal should have inbuilt mechanisms 
capable of responding to the rapid 
evolution of artemisinin resistance, 
particularly since there is currently no 
adequate pharmacological replacement 
for the artemisinin-class drugs. Beyond 
the general principle of combination 
therapy, there is no consensus on how 
to respond to or prevent the emergence 
and spread of drug resistance in the 
long term, although this is an active 
area of research [10–13]. If we can 
secure sustained adequate funding, 
and overcome all the political and 
operational obstacles, then the 
evolution of mosquito resistance 
to current insecticides and parasite 
resistance to current ACTs are the 
greatest dangers we face in our present 
attempts to control malaria [14]. 
Mathematical modeling is an important 
tool for developing strategies to contain 
the threat of resistance.
In the end, whether the goal is 
control, elimination, or eradication, a 
broad and sustainable plan is necessary 
to ensure that disease reductions 
are achieved and maintained. In the 
absence of such large-scale long-term 
planning, we risk the emergence 
of widespread antimalarial drug 
resistance, and in particular loss of the 
artemisinins, endangering the health 
of hundreds of millions of people who 
rely on these drugs as their primary 
malaria treatment [15]. Our planning 
and modeling efforts should focus on 
preserving the efficacy of our current 
drugs and insecticides as the minimum 
requirement for any chance of success 
in the control and eventual eradication 
of malaria.  
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